Joe O’Connell
National University of Ireland
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joe O’Connell.
Immunology Today | 1999
Joe O’Connell; Michael W. Bennett; Gerald C. O’Sullivan; J. Kevin Collins; Fergus Shanahan
Abstract Resistance to apoptosis through the Fas receptor pathway coupled with expression of the Fas ligand might enable many cancers to deliver a pre-emptive strike or counterattack against the immune system. Therapeutic exploitation of this has exciting potential, but now seems more complex and hazardous than was first evident.
Gut | 2002
Paul Ryan; Michael W. Bennett; Simon Aarons; Gary Lee; John Kevin Collins; Gerald C. O’Sullivan; Joe O’Connell; Fergus Shanahan
Background and aims: The uncertainty surrounding the role of Mycobacterium avium subsp paratuberculosis (Map) in Crohn’s disease has been compounded by possible contamination from Map present in the lumen microflora. This study used laser capture microdissection (LCM) and polymerase chain reaction (PCR) to detect Map DNA in subepithelial granulomas, isolated from 15 surgically resected, formalin fixed specimens of granulomatous Crohn’s disease and from 12 granulomatous disease controls (10 bowel, 2 non-bowel). Methods: The effect of amplicon size on reliability of PCR from formalin fixed samples was examined by amplifying 435 bp and 133 bp sequences of the human APC gene. After this, nested primers were designed to detect a small fragment (155 bp) of the Map specific IS900 gene in Crohn’s granulomas. LCM isolated granulomas from Map culture positive bovine intestine was used as positive control. PCR product specificity was confirmed by direct DNA sequencing. Results: The smaller, but not the larger, fragment of the APC gene amplified reliably in all samples. Amplification of the 155 bp fragment of the IS900 gene detected Map DNA in microdissected Crohn’s granulomas in 6 of 15 cases, and in 0 of 12 disease control granulomas. Conclusions: LCM can be used to detect Map DNA in granulomas in a proportion of patients with Crohn’s disease. However, formalin fixation requires that comparatively short DNA fragments of the Map specific IS900 gene be targeted, to permit consistent detection. Detection of Map DNA within granulomas might suggest an infectious aetiology in a subset of patients; alternatively, a transmissible agent may not be involved but mycobacterial DNA may influence pathogenesis by modifying the local cytokine responses.
Irish Journal of Medical Science | 2002
Paul Ryan; Michael W. Bennett; S. Aarons; G. Lee; Joe O’Connell; John Kevin Collins; Gerald C. O’Sullivan; Fergus Shanahan
ConclusionLCM of Crohn’s granulomas can be used to search for infectious agents by PCR. However, formalin fixation requires that relatively short DNA segments be targeted. These results suggest that a role for Map in a subset of cases of Crohn’s disease cannot be excluded.
Methods of Molecular Biology | 1998
Joe O’Connell; Triona Goode; Fergus Shanahan
Methods of Molecular Biology | 2002
Paul Ryan; Simon Aarons; Michael W. Bennett; Gary Lee; Gerald C. O’Sullivan; Joe O’Connell; Fergus Shanahan
Methods of Molecular Biology | 2002
Joe O’Connell
Methods of Molecular Biology | 2002
Triona Goode; Wen-Zhe Ho; Terry O’Connor; Sandra Busteed; Steven D. Douglas; Fergus Shanahan; Joe O’Connell
Methods of Molecular Biology | 2002
Joe O’Connell
Methods of Molecular Biology | 2002
Joe O’Connell
Methods of Molecular Biology | 2002
Joe O’Connell; Aileen Houston; Raymond Kelly; Darren O’Brien; Aideen E. Ryan; Michael W. Bennett; Kenneth Nally